Q4 2020 EyePoint Pharmaceuticals Inc Earnings Call Transcript
Good morning. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the EyePoint Pharmaceuticals Fourth Quarter and Year End 2020 Financial Results and Recent Corporate Developments Conference Call. (Operator Instructions) Please be advised this call is being recorded at the company's request.
I would now like to turn the call over to George Elston, Chief Financial Officer of EyePoint Pharmaceuticals.
Thank you, and thank you all for joining us on today's conference call to discuss EyePoint Pharmaceuticals Fourth Quarter and Year End 2020 Financial Results and Recent Corporate Developments. With me today is Nancy Lurker, President and Chief Executive Officer; Dr. Jay Duker, Chief Strategic Scientific Officer; and Scott Jones, Chief Commercial Officer. Nancy will begin with a review of recent corporate updates. Dr. Duker will then discuss pipeline developments for EYP-1901, and Scott will comment on recent
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |